Phosphorylation of the acidic domain of Mdm2 by protein kinase CK2

Mol Cell Biochem. 2005 Jun;274(1-2):85-90. doi: 10.1007/s11010-005-3074-4.

Abstract

The Murine double-minute clone 2 (Mdm2) onco-protein is the principal regulator of the tumour suppressor, p53. Mdm2 acts as an E3-type ubiquitin ligase that mediates the ubiquitylation and turnover of p53 under normal, unstressed circumstances. In response to cellular stress, such as DNA damage, the Mdm2-p53 interaction is disrupted. Part of the mechanism of uncoupling p53 from Mdm2-mediated degradation involves hypo-phosphorylation of a cluster of phosphorylated serine residues in the central acidic domain of Mdm2. Here, we show that two of the residues within this domain that are phosphorylated in vivo, Ser-260 and Ser-269, are phosphorylated by CK2 in vitro. Treatment of cells with the CK2 inhibitor, 4,5,6,7-tetrabromo-2-azabenzimidazole (TBB), leads to the induction of p53 and downstream targets of p53 including Mdm2 itself and p21. These data are consistent with the idea that CK2-mediated phosphorylation of Mdm2 may regulate Mdm2-mediated p53 turnover.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Casein Kinase II / antagonists & inhibitors
  • Casein Kinase II / genetics
  • Casein Kinase II / metabolism*
  • Cell Line
  • Humans
  • Phosphorylation
  • Protein Structure, Tertiary
  • Proto-Oncogene Proteins c-mdm2 / genetics
  • Proto-Oncogene Proteins c-mdm2 / metabolism*
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism
  • Serine / metabolism
  • Signal Transduction*
  • Triazoles / pharmacology
  • Tumor Suppressor Protein p53 / biosynthesis

Substances

  • 4,5,6,7-tetrabromo-2-azabenzimidazole
  • Recombinant Fusion Proteins
  • Triazoles
  • Tumor Suppressor Protein p53
  • Serine
  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2
  • Casein Kinase II